These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 581907)

  • 1. [Effect of ascorbic acid on the formation of excess amounts of p-hydroxyphenyllactic acid in lymphosarcoma].
    Ivanova VD; Baĭkova VN; Kaverzneva MM; Levinskiĭ MB
    Probl Gematol Pereliv Krovi; 1979 Apr; 24(4):25-8. PubMed ID: 581907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of formation of the blastomogenic metabolite of tyrosine - P-hydroxyphenyllactic acid in hemoblastoses].
    Ivanova VD; Baĭkova VN; Raushenbakh MO
    Probl Gematol Pereliv Krovi; 1978 May; 23(5):44-51. PubMed ID: 674148
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of the carcinogenic tyrosine metabolite p-hydroxyphenyllactic acid on the ascorbic acid concentration in the organs and blood of mice].
    Levchuk AA; Faron RA; Khrustalev SA; Raushenbakh MO
    Biull Eksp Biol Med; 1986 Oct; 102(10):462-3. PubMed ID: 3768514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of 4-hydroxyphenyllactic acid by Lactobacillus sp. SK007 fermentation.
    Mu W; Yang Y; Jia J; Zhang T; Jiang B
    J Biosci Bioeng; 2010 Apr; 109(4):369-71. PubMed ID: 20226379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital disorders of tyrosine metabolism and their correction in children with tumors].
    Baĭkova VN; Vares IM; Rybal'chenko VG; Shevchenko VE; Sotnikova EN
    Vopr Onkol; 1987; 33(11):42-8. PubMed ID: 3686921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aromatic compounds in certain infectious diseases].
    Kontsevaia NG; Shapiro SE; Kureeva RIa; Koval'skiĭ GS; Kondrat'ev VG
    Klin Med (Mosk); 1973 May; 51(5):77-80. PubMed ID: 4768972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of tyrosine balance and oxidation in oligophrenia of different origin].
    Ritsner MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(3):419-21. PubMed ID: 857531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Excretion of the blastomogenic tyrosine metabolite, p-hydroxyphenyllactic acid, in young children with hemoblastoses and their parents].
    Ivanova VD; Balakirev SA; Baĭkova VN; Maiakova SA; Vares IM
    Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):22-6. PubMed ID: 6972037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of methylcobalamin on the development of hemoblastoses induced by p-hydroxyphenyl lactic acid].
    Golenko OD; Kudriavtsev IA; Vares ; Miasishcheva NV
    Probl Gematol Pereliv Krovi; 1980 Feb; 25(2):22-6. PubMed ID: 6892658
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ochronotic arthropathy].
    Friis J
    Ugeskr Laeger; 1973 Dec; 135(49):2681-3. PubMed ID: 4592866
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion of p-hydroxyphenylpyruvic acid into homogentisic acid: possible participation of p-quinol intermediates.
    Schweizer J; Lattrell R; Hecker E
    Experientia; 1975 Nov; 31(11):1267-8. PubMed ID: 1204767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic hypoxia: accumulation of tyrosine metabolites in hepatocytes at low pO2.
    Jones DP; Mason HS
    Biochem Biophys Res Commun; 1978 Feb; 80(3):477-83. PubMed ID: 24444
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of dietary protein on tyrosine toxicity in the rat.
    Muramatsu K; Takei M; Nakamura K
    J Nutr; 1975 Apr; 105(4):439-46. PubMed ID: 234529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of ascorbic acid on the formation and leukemogenic action of p-hydroxyphenyllactic acid].
    Raushenbakh MO; Ivanova VD; Baĭkova VN; Vares IM; Levchuk AA
    Probl Gematol Pereliv Krovi; 1982 Jul; 27(7):3-6. PubMed ID: 7122455
    [No Abstract]   [Full Text] [Related]  

  • 15. Steric course of the NIH shift in the enzymic formation of homogentisic acid.
    Leinberger R; Hull WE; Simon H; Rétey J
    Eur J Biochem; 1981 Jul; 117(2):311-8. PubMed ID: 7274212
    [No Abstract]   [Full Text] [Related]  

  • 16. Tyrosinosis: a patient without liver or renal disease.
    Holston JL; Levy HL; Tomlin GA; Atkins RJ; Patton TH; Hosty TS
    Pediatrics; 1971 Sep; 48(3):393-400. PubMed ID: 5094340
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical basis for nutritional management of preterm infants.
    Räihä NC
    Pediatrics; 1974 Feb; 53(2):147-56. PubMed ID: 4149571
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oxidative catabolism of tyrosine in vitiligo].
    Kurbanov Kh; Berezov TT
    Vopr Med Khim; 1974; 20(4):379-82. PubMed ID: 4156814
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of massive doses of ascorbic acid on tyrosine metabolism in leukemic children].
    Baĭkova VN; Ivanova VD; Balakirev SA; Vares IM; Shevchenko VE
    Vopr Onkol; 1982; 28(9):28-34. PubMed ID: 6957069
    [No Abstract]   [Full Text] [Related]  

  • 20. Early effects of glucocorticoid treatment on amino acid metabolism in lymphosarcoma P1798.
    Stevens J; Stevens YW; Hollander VP
    Cancer Res; 1973 Feb; 33(2):370-4. PubMed ID: 4739450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.